Knowledge-based artificial neural networks (KBANNs) is a hybrid methodology that combines knowledge of a domain in the form of simple rules with connectionist learning. This combination allows the use of small sets of data (typical of medical diagnosis tasks) to train the network. The initial structure is set from the dependencies of a set of rules and it is only necessary to refine these rules by training. In this paper we present such KBANNs with a topology derived from knowledge elicited from the domain of metabolic features of malignant mammary tissues. KBANNs' performance is assessed over the classification of 26 in vivo 31 P spectra of normal and cancerous breast tissues. Results presented in this paper confirm the suitability of KBANNs a computational aid capable of classifying complex and limited data in a medical domain. The present study is part of an ongoing investigation into normal and abnormal breast physiology which may allow non-invasive early detection of breast cancer [29, 30] .
Introduction
The classification of 26 in vivo 31 P spectra of normal and cancerous breast tissues by neural networks (NNs) -networks without embedded knowledge -and KBANNs provides a real-life framework to assess the advantages of KBANNs over more traditional methods. 31 P is a non-invasive technique for the observation of a few, but highly critical phosphoruscontaining metabolites and intracellular pH, and the changes associated with energy demand/yield processes in living tissues. Normal tissues tend to maintain constant metabolite levels through a stable equilibrium between physiological processes. However, tissues like tumours often show altered levels of these metabolites as a result of disrupted cell function. Since 31 P MRS can obtain information from both normal and malignant tissues, it is possible to observe alterations in metabolism due to disrupted biochemical processes in cells. Changes observed in phospholipid metabolite concentrations, associated with differences in cell proliferation in malignant tissues have served as the basis for the identification of relevant features present in malignant but not in normal tissues. Identification of such dissimilarities is non-trivial and must be based on the understanding of the underlying mechanisms of altered cell metabolism. To explore the full potential of such a promising non-invasive technique, we propose KBANNs [18, 34, 35] as a suitable computational aid for the classification of scarce and complex data.
We defined the domain knowledge required by the symbolic component of KBANNs from a review of important contributions to this field and transformed it into a knowledge base of hierarchically structured inference rules. The elicitation process was guided by a variation of an interviewing technique [12] . Knowledge base refinement [6] and teachback interviewing [10] techniques were applied for further refinement of the knowledge base (a more detailed description of the complete elicitation process can be found in [28] ). Backpropagation learning algorithm [26] was used for the empirical learning in the connectionist component of KBANNs. Performance of both KBANNs and NNs are presented and results are discussed.
KBANNs
KBANNs are a synergistic combination of symbolic and empirical learning techniques. Strengths of one methodology overcome the weaknesses of the other, thus the combination of both approaches has a more robust performance than either method alone [18, 34, 35] . KBANNs have two modules. The symbolic module consists of a set of approximately correct rules. These rules reflect the dependencies in the knowledge base and determine the initial topology of a KBANN. This topology contains implicit knowledge from the domain which prevents the network from learning from scratch. It also indicates the features believed to be important for a correct classification; reduces training time and, more importantly, diminishes the necessity for large training data sets. The empirical learning module consists of a neural network supervised learning algorithm which refines the knowledge embedded in the network's topology. A set of examples is presented to the network until it reaches an acceptable accuracy in its responses.
31 P MRS of Malignant Mammary Tissues
The division and replacement of cells in normal tissues is controlled by feedback mechanisms that stimulate or inhibit the growth of normal cells. However, in the case of tumours, this mechanism is incapable of controlling the production of new cells and the division is done without any regard to the need for replacement, disrupting the structure of normal tissue. Alterations in cell membrane composition can occur with malignancy and could influence the levels of phospholipid precursors [1] . Smith et al. [27] have shown that tumours with high proliferation rates have higher concentrations of phosphocholine (PC) than slower growing ones. Similar results have been reported by other authors [2, 11, 21, 22, 25, 32] . Kalra et al. [11] , Leach et al. [13] and Ting et al. [33] found that an increase in phosphomonoesters (PMEs) and phosphodiesters (PDEs) is associated with cell activity present in rapid cell replication related to tumour growth and embryonic tissues. Thus, under certain circumstances the PME peak could provide relevant information about cell activity that could help in the interpretation of a spectrum from a tissue of suspected malignancy. Merchant et al. reported that the relative concentration of PE was significantly enhanced in malignant tissue compared to benign. They also reported that the most frequently observed metabolic characteristic of cancers is an increased PME and since PC and PE are intermediaries in the pathway of membrane synthesis, this elevation reflects alterations in membrane metabolism [15] . High concentrations of phosphodiesters PDEs are indicators of necrotic fraction in tumours as consequence of phospholipid degradation [3, 4, 25] . A prominent PME resonance level has also been observed in breast tumours [19] . Hence, PME could be considered as a diagnostic discriminant between benign and malignant tissues [7, 16, 31] .
The application of 31 P MRS to oncology can observe energy metabolism of cells by monitoring high-energy phosphates such as nucleoside tri-phosphate (NTP) and particularly adenosine tri-phosphate (ATP) which provides energy for cellular processes; inorganic phosphate (Pi), the by-product of energy expenditure; and phosphocreatine (PCr), an energy reservoir [9] . It also can determine tissue pH by measuring Pi chemical shift [13] . Levels of energy-rich compounds such as PCr and NTP tend to decline with tumour growth, whereas Pi tends to increase. In spite of the variety of methodologies used in the studies reviewed above, there are some common characteristics that reflect altered metabolic states in malignant tissues. High levels of PMEs, PDEs and Pi, being PMEs the most important marker, are considered indicators of tumour progression and response to treatment by most workers. ATP, a high-energy metabolite, is required in cellular processes, whereas PCr acts as an energy reservoir. These two metabolites and Pi are closely associated with cell activity [31] . Thus, low levels of ATP, low PCr and high Pi are indicators of increased cell activity related to tumours. These observations can provide some guidelines for the classification of mammary tumours. Further investigation of these techniques would be of considerable value for the understanding of cancer cell function and the role of phospholipid metabolism in tumour growth.
Knowledge Acquisition
During the knowledge acquisition process a set of statements about metabolic features of breast cancer tissues was defined. The extracted statements were grouped into different categories based on the metabolic feature they reflected. Similar statements were merged into a single statement. The simplified statements were transformed into a set of hierarchically structured If...then inference rules required by the KBANNs methodology [35] . The final set of rules was the result of a process which involved the elicitation of knowledge from several authors, and the refinement of the knowledge base.
The knowledge acquisition process was guided by a variation of an interviewing technique [12] since, in this case, the experts provided their knowledge through published work. Refinement of the knowledge base in Table 1 was done in collaboration with the experts. 1 A combination of knowledge base refinement [6] and teachback interviewing [10] was applied at this stage. References attached at the end of each rule indicate the sources of knowledge. Adjectives, such as high and low, referring to metabolite levels, energy levels or cell metabolic activity were eliminated, because they force the representation of knowledge into a more rigid and restricted format, which requires previous conceptualization from the user, reducing the generalization capabilities inherent to neural networks. Hence, the decision of whether a metabolite level or cell activity was high or low was left entirely to the network, based solely on the value associated to that entry. From the set of 9 rules in Table 1 , rules 5-9 were considered redundant and were deleted. Rule 6 was equivalent to rule 4, whereas rules 5, 7-9 did not provide any relevant information. While discussing the relevance of the antecedents in rule 3, one of the experts explained that from the three components of ATP, β-ATP is the metabolite that best reflects energy levels and gives the true amount of ATP. Thus, it was agreed to rewrite rule 3 as: R3: If β-ATP then tumour.
Further analysis indicated that rules 4, 3, 1 and 2 (in this order) are the most important. Thus, after refinement, the final knowledge base for metabolic features of breast tumours is presented in Table 2 . These rules will later be translated into the appropriate notation (see Section 6).
Data
A data set with 26 in vivo 31 P MR spectra from normal and cancerous mammary tissues was provided by the CRC Clinical Magnetic Resonance Research Group at the Royal Marsden Hospital, Sutton. It consists of 16 control cases obtained from four female premenopausal volunteers (ages 21-45), all with regular menstrual cycles and none using the contraceptive pill. Four 31 P spectra from each volunteer, one from each phase of the menstrual cycle, were acquired using a small surface coil positioned over the left breast, while the volunteer lay supine. Care was taken to avoid including signals from adjacent muscle. No loading correction was applied to the acquired spectra (a full description can be found in [20] ). The remaining 10 cases were acquired from five female patients (one premenopausal, four postmenopausal) with breast carcinoma. All patients were under treatment with chemotherapy, radiotherapy or tamoxifen. Two spectra per patient were provided. One measurement prior to treatment, and the second from a later stage of treatment to assess the tumour response. Tumours were located by palpation. A 5cm surface coil was placed over the tumour while patients lay supine. A series of measurements were performed and the resulting set of FIDs were fitted to a sin 2 function. Spectra were Fourier transformed and processed using Lorentzian model functions to model PME, Pi, PDE, PCr and α, β and γ ATP peaks. Tumour volume was assessed by either clinical or MRI section analysis (a full description of acquisition methods can be found in [14] ).
Methodology
KBANNs require a knowledge base of hierarchically structured inference rules, features and consequents, not all necessarily appear in the set of rules. The rules, written in a Lisp-like notation, define the topology and connection weights of a feed-forward network. The set of rules can contain AND, OR and NOT relationships. Rules are assumed to be conjunctive, non-recursive and variable-free. (For a more detailed explanation, see [35] ). The topology derived from the four rules and seven relations in the knowledge base in Table 2 used for these experiments is depicted in Figure 1 .
Rules and Features rule (1, ( (tumour, ?x) (pde level, value))). rule (2, ( (tumour, ?x) (pcr level, value))). rule(3, ( (tumour, ?x) (β-atp level, value))). rule (4, ( (tumour, ?x) (pme level, value))).
feature(1, (PME, real, (value)) ). feature(2, (PDE, real, (value)) ). feature(3, (Pi, real, (value)) ). feature(4, (PCr, real, (value)) ). feature(5, (α-ATP, real, (value)) ). feature(6, (β-ATP, real, (value)) ). feature(7, (γ-ATP, real, (value)) ). 
Results
840 NNs were trained with backpropagation. The complete set of 26 31 P MRS was used. All these networks had 7 inputs corresponding to the normalized peak area of PME, PDE, PCr, Pi, α-ATP, β-ATP and γ-ATP metabolites, and one output to indicate whether the input vector corresponds to a normal or a cancer spectrum. The number of hidden units varied from 1 to 20. For each topology, 42 networks were trained with different learning rate, momentum and seed values. The seed number was used to generate the initial random noise added to weights and biases. 42 KBANNs with the topology depicted in Figure 1 were trained with different learning rate, momentum and seed values. Table 3 : KBANNs and NNs performance.
From the aforementioned 42 KBANNs, the best five were retrained and tested using the leave one out method. All with average pattern/error values well below the average 0.0500. These networks were labeled cKBANN-1, cKBANN-2, cKBANN-3, cKBANN-4 and cKBANN-5. For each KBANN, a 25 fold cross-validation run test was set to evaluate their performance over new cases. Hence, each KBANN was trained with 25 cases and was tested over one unseen case. Training and testing performances during the cross-validation test are presented in Tables 4  and 5 respectively.
Further analysis of KBANNs' performance was carried to identify the nature and quantity of the errors. The type of error when a malignant case is classified as normal is defined as false negative, whereas a false positive error occurs when a normal case is classified as malignant. These results are presented in 
Conclusions
Results in the previous section show how KBANNs with a simple structure, such as the one derived from the set of four rules, can perform much better than NNs with more complex topologies but with no initial knowledge of the domain. The expertise gathered in the domain theory helps KBANNs overcome some of the difficulties during the learning process. Initial knowledge embedded in the KBANNs' topology reduces the need for large training sets and provides the network with an advantageous position at the beginning of the learning task. This expertise guides the network, through the space of possible solutions, to reach far better and more accurate results. Classification rates near 70% for the five KBANNs during testing in the cross-validation phase (Table 5 ) stress the ability of KBANNs to generalize over unseen cases. Further analysis of the spectra of misclassified cases is necessary to elucidate the underlying metabolic mechanisms that led to the classification errors.
In summary, the suitability of KBANNs for classification of complex and limited data was demonstrated in this medical domain. KBANNs showed better performance in classification of 31 P MRS of cancerous breast tissues than NNs. These experiments provide a sound base for further research into metabolic and structural alterations in cancerous cells of the breast.
